002332 仙琚制药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.5507.5716.83010.01614.563
总资产报酬率 ROA (%)1.2936.3075.6778.20211.130
投入资产回报率 ROIC (%)1.4907.2076.3899.22212.879

边际利润分析
销售毛利率 (%)59.46761.18757.48652.87658.155
营业利润率 (%)11.91612.56616.95215.67820.060
息税前利润/营业总收入 (%)12.19714.04611.59915.02119.297
净利润/营业总收入 (%)9.84012.0419.99613.63217.065

收益指标分析
经营活动净收益/利润总额(%)99.16287.110138.50598.73184.421
价值变动净收益/利润总额(%)-5.145-4.929-1.633-1.3995.661
营业外收支净额/利润总额(%)-1.04311.847-36.098-0.745-0.769

偿债能力分析
流动比率 (X)3.3213.1494.1953.2483.544
速动比率 (X)2.4352.2772.9982.3662.625
资产负债率 (%)15.73016.21115.87816.62818.263
带息债务/全部投入资本 (%)1.3842.5760.0696.5256.971
股东权益/带息债务 (%)6,986.3593,709.057137,054.2411,413.7521,318.096
股东权益/负债合计 (%)531.943512.860525.770497.607443.491
利息保障倍数 (X)30.192-67.273-13.536-27.753-31.642

营运能力分析
应收账款周转天数 (天)57.96452.09650.10548.24945.989
存货周转天数 (天)218.827227.656196.180167.981176.901